About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.Stay Connected
My Profile
I am an authority on regulatory aspects of communications and medical products, with particular emphasis on pre-approval communications; strategist to help pharma and biotech companies prepare best case for advisory committee approval; and counselor in issues and crisis management. I am a frequent speaker on various aspects of same - drug development, promotion, reimbursement and new media in a highly regulated environment. Author of books, newspaper and magazine pieces related to drug marketing and promotion as well as HIV specialty pieces. And of course... blogger!About This Blog
Eye on FDA is published by Mark Senak of FleishmanHillard’s New York office. The thoughts and ideas in this blog and postings are strictly my own and are not screened by my employer. Everything posted on this blog is my personal opinion and does not necessarily represent the views of FleishmanHillard or its clients.
Posts by Date
May 2024 M T W T F S S 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Twitter List
Legislative Tracking Tools
Category Archives: Legislation
Do We Really Know What Comparative Effectiveness Means?
To those who know me, it will come as no surprise to know that when it came time to choosing up sides for basketball during P.E. in grade school, junior high school and high school, I was always one of … Continue reading
Posted in Legislation
5 Comments
The Importance of Being Washington – The GAO Outlines FDA Reforms
Not the man, the city. On Sunday, January 25, the Washington Post carried an article entitled "The Height of Power – As Other American Fiefdoms Fade, Washington Looms Larger than Ever." It was a very interesting article analyzing the current … Continue reading
Posted in Legislation
Comments Off on The Importance of Being Washington – The GAO Outlines FDA Reforms
Ups and Downs of Health IT
There was an interesting article this weekend in the New York Times by Robert Pear "Privacy Issue Complicates Push to Link Medical Data" regarding the goal of the incoming Obama Administration to create jobs and great security from medical error … Continue reading
Posted in Industry Image, Legislation
Comments Off on Ups and Downs of Health IT
The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 1
Recently I have had the opportunity to take part in a number of talks about the future of the pharmaceutical market in a number of venues such as the Google Health Think 08 and a recent forum held by my … Continue reading
Posted in Current Affairs, FDA Policy, Legislation, Useful Resources
Comments Off on The Changing Policy and Communications Environment and Implications for Pharma Marketing, Part 1
A Guide to the Senate Elections
As we breathe a sigh of relief that the primaries are all finished, and the nominees identified, it is important to take note of the way the character of the election cycle as seen from various perspectives. It is, after … Continue reading
Posted in Legislation
Comments Off on A Guide to the Senate Elections